president Francisco Sagasti Announcing the signing of an agreement with Chinese pharmaceutical company Sinopharm for the supply of 38 million doses. Vaccine Against COVID-19 In a message to the nation, the president announced that the first million vaccines will arrive in January. Two times required
Read Also
- Vikings: Why Ivar’s Blue Eyes Are Dangerous to Boneless People | Vikings | Netflix Series | nnda nnlt | Fame Jan 15, 2021
- Get ready to see lots of ads in 3D on the internet Jul 10, 2020
- This is MALa, the world’s first crypto art museum Jul 6, 2021
- Quatennens case: The deputy will not participate in the LFI group of the Assembly until the court’s decision Nov 23, 2022
- Nvidia GeForce Now : SEGA games (and others) will leave the service at the end of may Jun 2, 2020
- The Teatre Principal hosts this Saturday the musical show ‘Black Box Music’ Apr 17, 2021
- 100 years of Doris Lessing: the brave author who stood up to injustice and pioneered feminism in literature Sep 18, 2020
This is the first agreement the Peruvian state has signed with a pharmaceutical company for the purchase of the vaccine.
Sinopharm vaccine is 79% effective and is “Conditional” for marketing from the Chinese health agency, Sinopharm is the first Chinese pharmaceutical group to report data on the effectiveness of vaccines in their preparations.
United Arab Emirates and Egypt It is the other two countries that have announced they have approved a vaccine made by Sinopharm with the Beijing Institute of Biological Products.
The efficacy rate of Sinopharm’s vaccine is lower than what competitors Pfizer / BioNTech (95%) and Moderna claim (94.1%).
Peru is part of the Phase III clinical trial of the Sinopharm vaccine. Thousands of people volunteer and receive both of these vaccines under the supervision of the Sinopharm. Cayetano Heredia Peruvian University (UPCH) and National University of San Marcos (UNMSM)
